Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 7
Results: 16
The antimalarial activity of 1,2,4‐trioxolane/trioxane hybrids and dimers: A review.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200077
- By:
- Publication type:
- Article
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200076
- By:
- Publication type:
- Article
Editorial Board: Arch Pharm (7/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202270015
- Publication type:
- Article
Cover Picture: Arch Pharm (7/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202270014
- Publication type:
- Article
Bis(2‐, 3‐, 4‐carboxyethylpyridinium) hexafluorosilicates as potential caries prophylactic agents.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200074
- By:
- Publication type:
- Article
Cardioprotective effect of silymarin nanoemulsion on 5‐fluorouracil‐induced cardiotoxicity in rats.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200060
- By:
- Publication type:
- Article
Cinnamic acid hybrids as anticancer agents: A mini‐review.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200052
- By:
- Publication type:
- Article
New quinoxalin‐2(1H)‐one‐derived VEGFR‐2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studies.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200048
- By:
- Publication type:
- Article
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200045
- Publication type:
- Article
QSAR‐driven synthesis of antiproliferative chalcones against SH‐SY5Y cancer cells: Design, biological evaluation, and redesign.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200042
- By:
- Publication type:
- Article
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200040
- By:
- Publication type:
- Article
Chondroprotection of fruit peels in a monosodium iodoacetate‐induced osteoarthritis rat model via downregulation of Col1A1.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200028
- By:
- Publication type:
- Article
New pyrimidine/thiazole hybrids endowed with analgesic, anti‐inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX‐2/sEH dual inhibition.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200024
- By:
- Publication type:
- Article
New 1,2,4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202100516
- By:
- Publication type:
- Article
Novel pyrazolo[3,4‐b]pyridine derivatives: Synthesis, structure–activity relationship studies, and regulation of the AMPK/70S6K pathway.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202100465
- By:
- Publication type:
- Article
Synthesis and antinociceptive activity of four 1H‐isoindolo‐1,3(2H)‐diones.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202100423
- By:
- Publication type:
- Article